190 related articles for article (PubMed ID: 2481833)
1. [Experience with prostate-specific antigen in patients with prostatic cancer].
Romics I; Bach D
Orv Hetil; 1989 Dec; 130(52):2797-800. PubMed ID: 2481833
[TBL] [Abstract][Full Text] [Related]
2. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
3. [Prostate-specific antigen. A new marker of prostatic pathology].
Boccon-Gibod L; Géraud M; Dugué MA
Ann Urol (Paris); 1988; 22(3):206-10. PubMed ID: 2456714
[TBL] [Abstract][Full Text] [Related]
4. [The value of the serum level of the prostate-specific antigen in prostatic pathology].
Théodon P; Rymer JC; Chopin D; Kouyoudjian JC; Abbou CC; Auvert J
Ann Urol (Paris); 1988; 22(3):199-205. PubMed ID: 2456713
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the diagnostic value of different tumor markers in prostatic cancer patients].
Romics I
Orv Hetil; 1992 Jun; 133(24):1485-7. PubMed ID: 1608614
[TBL] [Abstract][Full Text] [Related]
6. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
7. Pre-analytical and biological variability of prostatic acid phosphatase and prostate-specific antigen in serum from patients with prostatic pathology.
Panteghini M; Pagani F; Bonora R
Eur J Clin Chem Clin Biochem; 1992 Mar; 30(3):135-9. PubMed ID: 1376155
[TBL] [Abstract][Full Text] [Related]
8. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
Miki M
Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
[TBL] [Abstract][Full Text] [Related]
9. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
[TBL] [Abstract][Full Text] [Related]
10. [Tumor markers in prostate cancer].
Kuriyama M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1915-22. PubMed ID: 7521999
[TBL] [Abstract][Full Text] [Related]
11. [Role of prostate-specific antigen in prostatic carcinoma. Validity of an integrated methodologic approach and morpho-biological correlations].
Tomasino RM; Lo Bianco A; Cacciatore M; Pavone C; Carreca I; Morello V; Salvato M; Florena AM; Pavone-Macaluso M
Pathologica; 1989; 81(1072):109-26. PubMed ID: 2475847
[TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
[TBL] [Abstract][Full Text] [Related]
13. [Prostate specific antigen in serum of the patients with prostatic cancer].
Akimoto S; Akakura K; Fuse H; Shimazaki J
Hinyokika Kiyo; 1988 Apr; 34(4):636-42. PubMed ID: 2456678
[TBL] [Abstract][Full Text] [Related]
14. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
15. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
[TBL] [Abstract][Full Text] [Related]
16. [Value of serum PSA and PAP measurement with newly developed latex turbidimetric immunoassay].
Akino H; Tsuka H; Okada K; Tsuchiya Y; Matsubara M; Arimura K
Hinyokika Kiyo; 1995 Jun; 41(6):439-45. PubMed ID: 7544063
[TBL] [Abstract][Full Text] [Related]
17. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer?
Tarle M; Kraljić I
Anticancer Res; 1997; 17(3A):1531-4. PubMed ID: 9179191
[TBL] [Abstract][Full Text] [Related]
18. [Anatomoclinical and biologic correlations in prostatic pathology. Apropos of 150 case reports].
Amiel J; Chevallier D; Peyrottes A; Benoliel J; Toubol J
Ann Urol (Paris); 1989; 23(6):528-30. PubMed ID: 2482700
[TBL] [Abstract][Full Text] [Related]
19. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
Tarle M; Kovacić K; Kastelan M
Anticancer Res; 1993; 13(1):215-8. PubMed ID: 7682800
[TBL] [Abstract][Full Text] [Related]
20. Serum gamma-seminoprotein determination in prostatic cancer.
Shimazaki J; Akimoto S; Akakura K; Yoshiki T; Yoshida O; Okada K; Matsuoka K; Noda S; Eto K
Hinyokika Kiyo; 1991 Apr; 37(4):341-7. PubMed ID: 1716404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]